Rashes can be the ... viruses and cancer cells, and return the cleaned fluid to your circulation. They also house infection-fighting cells. You can’t typically feel your lymph nodes when you ...

Researchers from the Sant Pau Research Institute (IR Sant Pau), in collaboration with Sant Pau Hospital and the Josep ...

Liso-Cel is a type of CAR T-cell therapy — a revolutionary approach that uses a patient's own immune cells to fight cancer.

Best known for producing antibodies, B cells also guide other immune cells, specifically CD8 T cells, teaching them how to mount lasting defenses after vaccination. Researchers at the University ...

In a phase 1 trial involving 40 patients, the research group investigated the use of T cell ... The cell therapy was also well tolerated. Side effects such as fever or skin rash were mostly ...

for routine commissioning on the NHS in England for the treatment of some adults with certain forms of lymphoma. Yescarta – a CD19-directed genetically modified autologous T-cell immunotherapy ...

Cancers driven by hiccups in RNA processing can’t hide from our immune system, according to new work published today in Cell. A cross-institutional team ... Grant program through The Leukemia & ...

NICE has approved Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for diffuse large B-cell lymphoma (DLBCL) in adults who did not respond to two or more previous treatments. The drug will be ...

Defects in B cells make up 50 to 60 percent of primary immunodeficiency; common variable immunodeficiency (CVID), in which B cells don’t work normally ... to progress to lymphoma, a type ...

CAR T-cell therapy offers the possibility of long-term remission, even cure, for patients whose lymphoma resisted other treatments or has returned shortly after initial treatment. When a patient ...